Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.730
+0.230 (5.11%)
At close: Jan 22, 2026, 4:00 PM EST
4.470
-0.200 (-4.28%)
Pre-market: Jan 23, 2026, 8:01 AM EST
Camp4 Therapeutics Employees
Camp4 Therapeutics had 55 employees as of December 31, 2024. The number of employees decreased by 9 or -14.06% compared to the previous year.
Employees
55
Change
-9
Growth
-14.06%
Revenue / Employee
$69,127
Profits / Employee
-$970,873
Market Cap
242.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| Voyager Therapeutics | 172 |
| Tonix Pharmaceuticals Holding | 81 |
| Enlivex Therapeutics | 71 |
| Orchestra BioMed Holdings | 70 |
| Armata Pharmaceuticals | 60 |
| Ovid Therapeutics | 23 |
| Climb Bio | 18 |
CAMP News
- 6 days ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire
- 5 weeks ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewsWire